| 发明名称 | Anti-EMR1 antibodies | ||
| 摘要 | The invention provides anti-EGF-like module containing, mucin-like, hormone receptor-like 1 (EMR1) antibodies and methods of using such antibodies to treat EMR1-related diseases. | ||
| 申请公布号 | US9045539(B2) | 申请公布日期 | 2015.06.02 |
| 申请号 | US201213480937 | 申请日期 | 2012.05.25 |
| 申请人 | Kalobios Pharmaceuticals, Inc. | 发明人 | Luehrsen Kenneth;Baer Mark;Bebbington Christopher R.;Martinez David;Palath Varghese;Sujatha-Bhaskar Swathi;Tomasevic Nenad;Williams Jason;Yarranton Geoffrey T. |
| 分类号 | A61K39/395;G01N33/566;C07K16/28;A61K39/00 | 主分类号 | A61K39/395 |
| 代理机构 | Kilpatrick Townsend & Stockton LLP | 代理人 | Kilpatrick Townsend & Stockton LLP |
| 主权项 | 1. An isolated monoclonal anti-epidermal growth factor-like module containing, mucin-like, hormone receptor-like 1 (EMR1) antibody comprising a VH region and a VL region, wherein the antibody selectively binds to RDIDECRQDPSTCGPNSI (SEQ ID NO:30). | ||
| 地址 | South San Francisco CA US | ||